Author:
Duet M.,Mundler O.,Ajzenberg C.,Berolatti B.,Chedin P.,Duranteau L.,Warnet A.
Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging,General Medicine,Radiology Nuclear Medicine and imaging,General Medicine
Reference23 articles.
1. Reubi JC, Heitz PU, Landolt AM. Visualization of somatostatin receptors and correlation with immunoreactive growth hormone and prolactin in human pituitary adenomas: evidence for different tumor subclasses. J Clin Endocrinol Metab 1987;65: 65?73.
2. Bertherat J, Brue T, Enjalbert A, et al. Somatostatin (SRIH) receptors on thyrotropin (TSH)-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions. J Clin Endocrinol Metab 1992;75: 540?546.
3. Levy A, Eckland DJA, Gurney AM, Reubi JC, Doshi R, Lightman SL. Somatostatin and thyrotropin-releasing hormone response and receptor status of a thyrotropin-secreting pituitary adenoma, clinical and in vitro studies. J Neuroendocrinol 1989;1: 321?326.
4. Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WAP, Kooij PPM, Oei HY, van Hagen M, Postema PTE, de Jong M, Reubi JC, Visser TJ, Reijs AEM, Hofland LJ, Koper JW, Lamberts SWJ. Somatostatin receptor scintigraphy with (111In-DTPA-D-Phe1)-and (123I-Tyr3)-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993;20: 716?729.
5. Nocaudie M, Huglo D, Deveaux M, Proye C, Marchandise X. Scintigraphie à lïode 123-Tyr-3-octréotide et attitudes thérapeutiques. A propos de trois cas. Médecine Nucléaire, Imagerie fonctionnelle et métabolique 1993;17: 74?80.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献